BML-259는 CDK5(IC50 = 64nm) 및 CDK2/사이클린 E(IC50 = 98nm)의 강력한 억제제입니다.
BML-259 (CAS 267654-00-2) 참고자료
Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer's disease: C.J. Helal, et al.; Bioorg. Med. Chem. Lett. 14, 5521 (2004)
의 억제제:
Cdk2, Cdk5, Rad9B, Ser/Thr Protein Kinase.
건강 상태 :
Solid
용해도 :
30mg/ml soluble in DMSO or dimethyl formamide, 0.25mg/ml soluble in 100% ethanol